‫פרטים על חברי הפאנל‬
Mr Avi Meizler founded (1990) and was the President until June, 2012 of Meizler UCB
Biopharma S.A. Mr. Meizler is Co-founded and CEO Advantech Bioscience Pharmaceutical
Ltd, being responsible for the development of 02 biological components. Investor and
Director of the board of Therapix Bioscience Ltd, Orimune Bio, Kadimastem Stem Cellss,
Raziel Therapeutics, Nirolin lifescience. He has been an experienced businessman and
entrepreneur in Brazil since 1979 in the fields of pharmaceuticals, engineering and
construction.
Dr. Cláudio Lottenberg is a current Director at ADVANCE Medical, and was previously
a Former Independent Director at Cremer SA. Dr. Lottenberg is President of the Board of
Directors of Albert Einstein Hospital, ranked the #1 hospital in Latin America. Dr.
Lottenberg is a former Secretary of Health for Sao Paulo. Dr. Lottenberg is one of the
most well respected ophthalmologists in Brazil, and received in 2009 the Medalha
Moacyr Alvaro, the most prestigious award in ophthalmology.
Mr Ronen Hausirer is a partner in the technology licensing group within the High-tech
department at HFN. Specializing in commercial transactions between Israeli companies
and major corporations in Asia, Europe and the U.S., Ronen advises clients from a range
of industries including medical device, pharmaceuticals and bio-tech companies in a
variety of transactions. Ronen specializes in technology licensing, technology transfer,
general commercial transactions, joint ventures and strategic collaborations.
Albert Einstein Hospital in Brazil is the first Bone Marrow Transplantation Center in
Latin America to receive FACT accreditation. HIAE is accredited for antilogous and
allergenic transplantation. The hospital was founded in 1971 with the mission of providing
quality health care, generating knowledge, and promoting social responsibility. In recent
decades, an expansion plan doubled the hospital’s service area, expanded social
programs of assistance to needy communities, and turned the hospital into a benchmark
in organ transplants, in the public sector. HIAE works in close partnerships with
governments for health assistance in various regions of São Paulo metropolis. The
hospital’s research and educational institute has already trained approximately 130,000
professionals and conducts hundreds of studies annually.